Credit: Sam Ogden
Kenneth Anderson, MD, and his colleagues at Dana-Farber determined that P5091, a small molecule inhibitor of USP7 decreases the level of a cancer-promoting protein called HDM2, which has the effect of bolstering p53 and p21, a gene that suppresses tumor cell growth. The result is that the myeloma cells stopped growing and began to die.